TRANSTHERA-B(02617) plans to implement full circulation of H shares.

TRANSTHERA-B (02617) announces that on October 20, 2025, the Board of Directors of the company has considered and approved the submission of an application to the China Securities Regulatory Commission to convert 44.9711 million shares of the company's domestic shares held by 10 shareholders into H shares, accounting for approximately 11.33% of the total issued shares of the company as of the date of this announcement. Upon obtaining all relevant approvals (including those from the China Securities Regulatory Commission and the Hong Kong Stock Exchange) and complying with all applicable laws, regulations, and rules, these domestic shares will be converted into H shares and will be eligible for listing and trading on the main board of the Hong Kong Stock Exchange.